In this episode, our host Maryam Tabatabai is joined by three guests Olivia Pane, PharmD; Dr. Edmundo Rodriguez Frias; and Katie Lockhart, who unpack insights from Prime Therapeutics’ latest clinical report that dives into the latest evidence-based clinical insights related to the rising prevalence and significant health impact of metabolic dysfunction-associated steatohepatitis, or MASH. MASH is a silent but serious liver condition affecting over 22 million Americans, with numbers projected to rise sharply by 2030.

Listeners learn about the latest major development in liver health treatment: the FDA approval of Novo Nordisk’s semaglutide – Wegovy -- as the first GLP-1 drug indicated for MASH. We explore how this development may revolutionize care and could offer a more affordable alternative to treating this condition.

The Evolution of GLP-1s
www.primetherapeutics.com
All Pharmacy Friends episodes

Metabolic dysfunction-associated steatohepatitis (MASH) – A new era in liver health

The views and opinions expressed by the guest featured on this podcast are their own and do not necessarily reflect the official policy or position of Prime Therapeutics LLC, its hosts, or its affiliates. The guest's appearance on this podcast does not imply an endorsement of their views, products, or services by Prime Therapeutics LLC. All content provided is for informational purposes only and should not be construed as professional advice

Culture isn’t just a vibe — it’s a strategy. In this Pharmacy Friends episode, Prime's Erin Feigal (CHRO) and Jeff Kaczrowski (Director of Talent Acquisition) join host Laura Spitzack to explore how culture sparks innovation, drives engagement, and delivers real business results and why ignoring the idea of culture is like ignoring gravity.

From cultural commitments to leadership styles, hear how Prime’s 7,000+ employees band together to deliver results, innovate for growth, win together and do what’s right.

Whether you're leading a team or just trying to survive the next all-hands, tune in for sharp insights and how bold ideas—from mild to wild—prove culture is the ultimate business accelerator.

More about Prime's culture

Apply for a job at Prime

www.primetherapeutics.com

Health care is constantly evolving, especially in the realm of medical pharmacy. Prime Therapeutics (Prime) has been tracking that evolution for 15 years through its annual Medical Pharmacy Trend Report, where Prime experts examine trends, analyze data and share drug forecasts to help health plans and health care leaders make the best prescribing and coverage decisions.

In the most recent episode of the Pharmacy Friends podcast, host Maryam Tabatabai, PharmD, vice president of clinical information, sat down with three leading experts — Kristen Reimers, senior vice president of specialty clinical solutions; Lisa Polakowski, director of the Medical Pharmacy Trend Report; and Ben Messerli, actuarial manager — to reflect on the history and future of this cornerstone report.

Stay tuned for the release of the Medical Pharmacy Trend Report this fall.

Want to be included in next year's research or need a printed version of of the report? Send us an email.

Follow us on our website and social channels.

https://www.primetherapeutics.com

Newsroom

LinkedIn

"Pharmacy Friends" is a podcast dedicated to bringing industry experts to the same table to talk about what is happening in pharmacy today, what is coming in the future and, most importantly, what it means to you.

Other ways to listen:

Amazon Music | Apple | Spotify